Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
Osteosarcoma (OS) is a commonly occurring primary malignant bone cancer with serious impact and high mortality, yet effective and safe therapy method not available. The aim of the present study was to elucidate the antitumor effect of telmisartan on human osteosarcoma cells in vitro and its underlyi...
Main Authors: | Wang Chao, Wang Wen-Bo |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2018-07-01
|
Series: | Open Life Sciences |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/biol.2018.13.issue-1/biol-2018-0029/biol-2018-0029.xml?format=INT |
Similar Items
-
Biological Aspects of mTOR in Leukemia
by: Simone Mirabilii, et al.
Published: (2018-08-01) -
mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01) -
Prucalopride inhibits the glioma cells proliferation and induces autophagy via AKT-mTOR pathway
by: Hong Qiao, et al.
Published: (2018-06-01) -
TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis
by: Guo-sheng Zhao, et al.
Published: (2018-08-01) -
Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway
by: Hongying Liu, et al.
Published: (2018-06-01)